US Stock MarketDetailed Quotes

XCUR Exicure

Watchlist
  • 14.0000
  • +0.0900+0.65%
Close Mar 27 16:00 ET
88.45MMarket Cap-2.95P/E (TTM)

About Exicure Company

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Company Profile

SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Andy Yoo
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700

Company Executives

  • Name
  • Position
  • Salary
  • Paul Kang
  • Co-Chief Executive Officer
  • 20.00K
  • Andy Yoo
  • Director, Chief Executive Officer and President
  • 2.17K
  • Seung Ik Baik
  • Director, Chief Financial Officer and Secretary
  • 2.17K
  • Joshua Miller
  • Chief Accounting Officer
  • --
  • Sangwook Song
  • Director
  • 645.00
  • Ho Jung John
  • Director
  • 645.00
  • Minwoo Kang
  • Independent Director
  • 645.00
  • Dongho Lee
  • Independent Director
  • 20.00K
  • Chang Keun Choi
  • Independent Director
  • 645.00

Market Insights

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More